Skip to content
  • Clinical Studies
  • Pharma GMP
  • Pharma Tips
  • Stability Studies
  • Pharma Books
  • Schedule M

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

Aerosol: SOP for Reporting and Reviewing Validation Data – V 2.0

Posted on By

Aerosol: SOP for Reporting and Reviewing Validation Data – V 2.0

SOP for Reporting and Reviewing Validation Data

Department Aerosol
SOP No. SOP/Aerosol/119/2025
Supersedes SOP/Aerosol/119/2022
Page No. Page 1 of Y
Issue Date 06/02/2025
Effective Date 16/02/2025
Review Date 06/02/2028

1. Purpose

This Standard Operating Procedure (SOP) outlines the process for reporting and reviewing validation data in aerosol manufacturing. The purpose of this SOP is to ensure that validation data is accurately recorded, appropriately analyzed, and thoroughly reviewed to confirm that the process and equipment meet all specified requirements. Proper reporting and review of validation data are critical for ensuring product quality, compliance with regulatory requirements, and continued process improvement.

2. Scope

This SOP applies to all validation data generated during the validation of aerosol manufacturing processes at [Company Name]. It covers data from process validation, equipment qualification, cleaning validation, and any other validation activities. The SOP ensures that all validation data is accurately documented, reviewed, and retained for future audits and regulatory inspections.

3. Responsibilities

  • Validation Team: Responsible for collecting and recording validation data during validation runs, ensuring that data is complete, accurate, and meets the protocol’s requirements.
  • Quality Assurance (QA) Team: Responsible for reviewing and verifying the completeness, accuracy, and compliance of the validation data with GMP and regulatory guidelines.
  • Production Team: Responsible for assisting with the collection of data and
providing process-related information to ensure validation runs are properly documented.
  • Regulatory Affairs Team: Ensures that validation data is compiled in accordance with applicable regulatory standards and guidelines, and supports the preparation for regulatory submissions or audits.
  • 4. Accountability

    The Manufacturing Manager is accountable for ensuring that validation data is properly documented and reviewed according to this SOP. The overall compliance with this SOP is overseen by the Quality Assurance (QA) Manager.

    5. Procedure

    5.1. Collecting Validation Data

    1. Validation data should be collected during each stage of the validation process. The following types of data should be recorded:
      • Process parameters (e.g., filling speed, pressure, temperature)
      • Quality attributes (e.g., appearance, spray rate, chemical composition)
      • Equipment performance data (e.g., calibration results, machine settings)
      • Environmental conditions (e.g., temperature, humidity in the manufacturing area)
      • Deviation reports (if applicable)
    2. The data should be recorded in real-time during the validation process to ensure accuracy. This can be done manually or using automated data collection systems.
    3. Data should be recorded in the Validation Batch Record (Annexure-1) or any other relevant validation documentation.

    5.2. Documenting Validation Data

    1. Validation data should be documented in a clear and organized manner. The following documentation is required:
      • Validation Batch Record: This record should contain all data collected during the validation process, including process parameters, quality control results, and equipment performance data. It should also include any deviations or non-conformities and corrective actions taken (Annexure-1).
      • Process Monitoring Logs: These logs should document the monitoring of critical process parameters (CPPs) during the validation process.
      • Deviation Log: Any deviations from the established protocols should be documented, including the cause of the deviation and corrective actions (Annexure-2).
    2. The documentation must be signed by the operator performing the validation and reviewed by the QA team to ensure accuracy and completeness.

    5.3. Reviewing Validation Data

    1. Once the validation data has been collected and documented, the QA team should review the data to verify the following:
      • All critical parameters have been monitored and recorded according to the validation protocol.
      • The data complies with predefined acceptance criteria.
      • Any deviations from the protocol have been appropriately documented and corrected.
      • Corrective actions taken in response to deviations have been effective and are properly documented.
    2. The QA team should also evaluate whether the data supports the conclusion that the process or equipment is capable of consistently producing a product that meets specifications.
    3. If the data review reveals any gaps or issues, the QA team should request further investigations or re-validation, as needed, and ensure that all corrective actions are implemented.

    5.4. Reporting Validation Data

    1. Once the data review is complete, the final validation report should be prepared. The validation report should summarize the following:
      • The purpose and scope of the validation
      • The validation protocol and acceptance criteria
      • All data collected during the validation process
      • Results of the review of the data and compliance with acceptance criteria
      • Any deviations observed, along with corrective actions taken
      • Conclusions regarding the validation outcome
    2. The final validation report should be signed and approved by the QA team and relevant department heads.
    3. The report should be stored in the appropriate location (electronic or physical) for future reference and regulatory audits.

    5.5. Retaining Validation Data

    1. Validation data and reports must be retained for a minimum of 3 years or as required by regulatory guidelines. This includes:
      • All batch records and monitoring logs
      • Deviation logs and corrective action documentation
      • Final validation reports
    2. Validation data should be stored in a secure and organized manner, either electronically or in paper format, depending on the company’s record-keeping system.
    3. Access to validation data should be restricted to authorized personnel, and data should be readily available for internal audits, regulatory inspections, or process reviews.

    6. Abbreviations

    • GMP: Good Manufacturing Practice
    • QA: Quality Assurance
    • SOP: Standard Operating Procedure
    • CPP: Critical Process Parameter
    • CFR: Code of Federal Regulations
    • OQ: Operational Qualification
    • PQ: Performance Qualification

    7. Documents

    1. Validation Batch Record (Annexure-1)
    2. Deviation Log (Annexure-2)
    3. Validation Report (Annexure-3)

    8. References

    This SOP is based on the following regulatory guidelines and industry standards:

    • Good Manufacturing Practice (GMP) Guidelines
    • FDA Code of Federal Regulations (CFR) Title 21, Part 211
    • International Council for Harmonisation (ICH) Guidelines

    9. SOP Version

    Version: 2.0

    10. Approval Section

    Prepared By Checked By Approved By
    Signature
    Date
    Name
    Designation
    Department

    11. Annexures

    Annexure-1: Validation Batch Record

    Batch Number Test Date Test Parameters Test Results Operator Name
    Batch-001 10/02/2025 Filling volume, spray rate, appearance Pass Rajesh Patel

    Annexure-2: Deviation Log

    Deviation ID Deviation Description Corrective Action Responsible Person Status
    DEV-12345 Filling speed deviation Adjusted machine settings Rajesh Patel Completed

    12. Revision History:

    Revision Date Revision No. Revision Details Reason for Revision Approved By Page No. Ref. Point No. Details of Revision
    01/01/2024 V 1.0 Initial Release First Issue Anjali Sharma Page 1 [Ref Point] First Release
    01/01/2025 V 2.0 Updated procedures To comply with updated GMP regulations Anjali Sharma Page 1 [Ref Point] Updated procedures
    See also  Aerosol: SOP for Cross-Contamination Prevention in Dispensing Areas - V 2.0
    Aerosols V 2.0 Tags:Aerosol Batch Production, Aerosol Can Design, Aerosol Cold Filling, Aerosol Documentation Standards, Aerosol Emissions Control, Aerosol Environmental Regulations, Aerosol equipment calibration, Aerosol Filling Process, Aerosol Fire Safety Measures, Aerosol Formulation, Aerosol Good Manufacturing Practice (GMP), Aerosol Hazardous Materials Handling, Aerosol Incident Reporting, Aerosol Leak Testing, Aerosol Maintenance Schedules, Aerosol Personal Protective Equipment (PPE), Aerosol Pressure Filling, Aerosol Product Labeling, Aerosol Product Testing, Aerosol Propellant Selection, Aerosol quality control, Aerosol Regulatory Compliance, Aerosol Risk Assessment, Aerosol Safety Protocols, Aerosol Standard Operating Procedures (SOPs), Aerosol Storage Requirements, Aerosol Training Programs, Aerosol Valve Crimping, Aerosol Ventilation Systems, Aerosol Waste Disposal

    Post navigation

    Previous Post: SOP for Ensuring Proper Use of Warehouse Storage Automation Systems – V 2.0
    Next Post: API Manufacturing: SOP for Line Clearance Before Start of Manufacturing – V 2.0

    Standard Operating Procedures V 1.0

    • Aerosols
    • Analytical Method Development
    • Bioequivalence Bioavailability Study
    • Capsule Formulation
    • Clinical Studies
    • Creams
    • Data Integrity
    • Dental Dosage Forms
    • Drug Discovery
    • Environment, Health and Safety
    • Formulation Development
    • Gels
    • Good Distribution Practice
    • Good Warehousing Practices
    • In-Process Control
    • Injectables
    • Liquid Orals
    • Liposome and Emulsion Formulations
    • Lotions
    • Lyophilized Products
    • Maintenance Dept.
    • Medical Devices
    • Metered-Dose Inhaler
    • Microbiology Testing
    • Nanoparticle Formulation
    • Nasal Spray Formulations
    • Nebulizers
    • Ocular (Eye) Dosage Forms
    • Ointments
    • Otic (Ear) Dosage Forms
    • Pharmacovigilance
    • Powder & Granules
    • Purchase Departments
    • Quality Assurance
    • Quality Control
    • Raw Material Stores
    • Regulatory Affairs
    • Tablet Manufacturing
    • Rectal Dosage Forms
    • Transdermal Patches
    • Vaginal Dosage Forms
    • Validations and Qualifications

    Read SOPs in your Language:

     - 
    Bengali
     - 
    bn
    English
     - 
    en
    Gujarati
     - 
    gu
    Hindi
     - 
    hi
    Malayalam
     - 
    ml
    Marathi
     - 
    mr
    Punjabi
     - 
    pa
    Tamil
     - 
    ta
    Telugu
     - 
    te

    NEW! Revised SOPs – V 2.0

    • Aerosols V 2.0
    • API Manufacturing V 2.0
    • BA-BE Studies V 2.0
    • Biosimilars V 2.0
    • Capsules V 2.0
    • Creams V 2.0
    • Ointments V 2.0
    • Raw Material Warehouse V 2.0
    • Tablet Manufacturing V2.0

    New Publication: A must for All.

    Copyright © 2025 SOP Guide for Pharma.

    Powered by PressBook WordPress theme

    Go to mobile version